XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 50 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $72,000 | +242.9% | 29,541 | +476.6% | 0.00% | – |
| Q2 2021 | $21,000 | -87.9% | 5,123 | -86.8% | 0.00% | – |
| Q1 2021 | $174,000 | +135.1% | 38,750 | +158.3% | 0.00% | – |
| Q4 2020 | $74,000 | -41.3% | 15,003 | -28.9% | 0.00% | – |
| Q3 2020 | $126,000 | +129.1% | 21,110 | +2.6% | 0.00% | – |
| Q2 2020 | $55,000 | +150.0% | 20,578 | +80.4% | 0.00% | – |
| Q1 2020 | $22,000 | -88.3% | 11,404 | -57.3% | 0.00% | – |
| Q4 2019 | $188,000 | +41.4% | 26,692 | +97.1% | 0.00% | – |
| Q3 2019 | $133,000 | -32.5% | 13,539 | -21.2% | 0.00% | – |
| Q2 2019 | $197,000 | +223.0% | 17,190 | +182.5% | 0.00% | – |
| Q1 2019 | $61,000 | +306.7% | 6,086 | +622.8% | 0.00% | – |
| Q4 2018 | $15,000 | -65.9% | 842 | -66.0% | 0.00% | – |
| Q3 2018 | $44,000 | – | 2,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |